Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
WaFd
WAFD
$2.81B
| $9.59M | 0.01% |
261,573
-127,127
| -33% | -$4.67M |
|
1477
Arbor Realty Trust
ABR
$955M
| $9.58M | 0.01% |
667,840
+250,400
| +60% | +$3.56M |
|
|
VNET
1478
VNET Group
VNET
$2.17B
| $9.58M | 0.01% |
1,321,267
+166,500
| +14% | +$1.26M |
|
|
INN
1479
Summit Hotel Properties
INN
$659M
| $9.57M | 0.01% |
775,231
-215,121
| -22% | -$2.58M |
|
|
TNAV
1480
DELISTED
Telenav Inc.
TNAV
| $9.56M | 0.01% |
1,967,565
+380,196
| +24% | +$1.85M |
|
1481
Huntsman Corp
HUN
$1.79B
| $9.55M | 0.01% |
395,200
+80,900
| +26% | +$1.87M |
|
1482
Moog Inc Class A
MOG.A
$13.9B
| $9.54M | 0.01% |
111,800
+89,300
| +397% | +$7.63M |
|
1483
Home Bancorp
HBCP
$569M
| $9.54M | 0.01% |
243,393
+2,693
| +1% | +$105K |
|
1484
Tejon Ranch
TRC
$443M
| $9.52M | 0.01% |
596,000
+102,100
| +21% | +$1.67M |
|
1485
GoPro
GPRO
$110M
| $9.51M | 0.01% |
2,192,048
-1,814,252
| -45% | -$7.53M |
|
1486
Associated Banc-Corp
ASB
$6.1B
| $9.49M | 0.01% |
430,569
-160,062
| -27% | -$3.38M |
|
|
ACBI
1487
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $9.49M | 0.01% |
517,008
+75,900
| +17% | +$1.39M |
|
|
EGRX
1488
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $9.41M | 0.01% |
156,700
+120,400
| +332% | +$7.18M |
|
|
SOGO
1489
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
| $9.39M | 0.01% |
2,063,016
+1,273,216
| +161% | +$6.47M |
|
1490
Rocky Brands
RCKY
$355M
| $9.36M | 0.01% |
317,992
+54,500
| +21% | +$1.61M |
|
|
QUOT
1491
DELISTED
Quotient Technology Inc
QUOT
| $9.36M | 0.01% |
949,200
+409,900
| +76% | +$3.93M |
|
1492
Invesco Preferred ETF
PGX
$3.77B
| $9.35M | 0.01% |
622,978
+266,582
| +75% | +$3.98M |
|
1493
Brunswick
BC
$5.28B
| $9.32M | 0.01% |
155,400
-76,700
| -33% | -$4.44M |
|
1494
Terex
TEX
$7.76B
| $9.27M | 0.01% |
311,300
+175,900
| +130% | +$4.94M |
|
1495
CEVA Inc
CEVA
$908M
| $9.23M | 0.01% |
342,400
+36,700
| +12% | +$1M |
|
|
AMED
1496
DELISTED
Amedisys
AMED
| $9.21M | 0.01% |
55,200
+44,100
| +397% | +$6.56M |
|
|
ESSA
1497
DELISTED
ESSA Bancorp
ESSA
| $9.21M | 0.01% |
543,161
+18,319
| +3% | +$305K |
|
|
RTL
1498
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $9.19M | 0.01% |
692,933
+163,200
| +31% | +$2.33M |
|
|
IPHS
1499
DELISTED
Innophos Holdings, Inc.
IPHS
| $9.18M | 0.01% |
287,000
-608,600
| -68% | -$19.6M |
|
1500
CEMIG Preferred Shares
CIG
$5.46B
| $9.15M | 0.01% |
5,263,339
-700,661
| -12% | -$1.14M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.